Algeta ASA : Algeta schedules first half and second quarter 2013 results presentation, webcast and conference call

- Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, will announce its first half and second quarter 2013 results on Wednesday, 28 August 2013. A presentation by members of Algeta's executive management team to investors, analysts and the press will take place in Oslo at 10:00 CET.

The presentation will also be webcast live and can be accessed through www.algeta.com where questions can also be submitted during the presentation.

The presentation will take place at 10:00 CET at:

KS-Agenda Møtesenter
Haakon VIIs gate 9
0161 Oslo
Norway.

Algeta will also host an international conference call at 14:30 CET/08:30 Eastern Time (US) (details below).  

To participate in the conference call, please dial the appropriate number below five minutes prior to the call:

US: +1 877 423 0830
UK: +44 20 7153 9154
Norway: +47 21 06 61 13
Sweden: +46 8-506 443 86
Denmark: +45 32 71 42 62
Switzerland: +41 44 580 65 22

Participant pin code: 197187#

***

To access the replay, please dial:

US: +1 877 679 2989
UK: +44 203 364 5200
Norway: +47 23 50 02 03
Sweden: +46 8-505 564 73

Conference reference: 348084#

A replay of the conference call will also be available at www.algeta.com.

The results report and the presentation will be available at www.algeta.com in the Investors section from 07:00 CET.

###

For further information, please contact:

About Algeta

Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit www.algeta.com.